Home LiteratureArticle Details
PMID: 16736 Published · ppublish English Journal Article Review

Interactions with antiepileptic drugs.

Drugs ·Vol. 13 ·No. 4 ·1977-04-00 ·Pages 266-75

Richens A

Abstract

Most of the currently available antiepileptic drugs have a low therapeutic ratio and therefore a drug interaction causing elevation of the serum level of one of these compounds can readily lead to drug intoxication. Phenytoin, in particular, is vulnerable because its metabolism is dose-related and at therapeutic serum levels the enzyme system involved in its degradation is easily inhibited by concurrent drug administration. As multiple drug therapy has traditionally been practised in the management of epilepsy, clinically important interactions are common. Furthermore, most of the drugs used in the treatment of major epilepsies are potent inducers of hepatic microsomal enzymes and can therefore stimulate the metabolism of concurrently-administered drugs to such an extent that they may be rendered ineffective. The use of one drug alone is recommended, where possible, in the management of epilepsy.

MeSH Terms
Acetaminophen/pharmacology Acetazolamide/pharmacology Anti-Anxiety Agents/pharmacology Anticoagulants/pharmacology Anticonvulsants/blood,pharmacology Carbamazepine/pharmacology Diazepam/pharmacology Drug Interactions Furosemide/pharmacology Gonadal Steroid Hormones/pharmacology Griseofulvin/pharmacology Humans Phenobarbital/pharmacology Phenytoin/blood Primidone/pharmacology Thiazines/pharmacology Urea/analogs & derivatives,pharmacology Valproic Acid/pharmacology Vitamin D/pharmacology
Chemicals
Anti-Anxiety Agents Anticoagulants Anticonvulsants Gonadal Steroid Hormones Thiazines Primidone Vitamin D Griseofulvin Carbamazepine Acetaminophen Valproic Acid Phenytoin Furosemide Urea Acetazolamide Diazepam Phenobarbital
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Richens A
References (50)
50 references, click to expand
  1. Controlled trial of sodium valproate in severe epilepsy.
    Br Med J. 1975 Nov 1;4(5991):255-6 PMID: 1104059
  2. Effect of diphenylhydantoin on the metabolism of dicoumarol in man.
    Acta Med Scand. 1971 Jan-Feb;189(1-2):15-9 PMID: 4107730
  3. Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.
    J Clin Endocrinol Metab. 1969 Dec;29(12):1553-8 PMID: 4310497
  4. The effect of phenyramidol on the metabolism of diphenylhydantoin.
    Clin Pharmacol Ther. 1967 Jul-Aug;8(4):554-6 PMID: 4951971
  5. Ethanol metabolism and ethanol-drug interactions.
    Biochem Pharmacol. 1976 Apr 15;25(8):869-75 PMID: 773384
  6. Acute diphenylhydantoin intoxication following halothane anesthesia.
    J Pediatr. 1970 Jun;76(6):941-4 PMID: 5444592
  7. Preliminary observations of serum carbamazepine concentration in epileptic patients.
    Neurology. 1973 Apr;23(4):357-66 PMID: 4736124
  8. Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications.
    Drugs. 1976 Dec;12(6):442-8 PMID: 1001220
  9. Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.
    Neurology. 1966 Jun;16(6):594-602 PMID: 5949235
  10. Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.
    Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):249-54 PMID: 1233220
  11. Interaction of quinidine with anticonvulsant drugs.
    N Engl J Med. 1976 Mar 25;294(13):699-702 PMID: 1250281
  12. Interaction of phenytoin and primidone.
    Br Med J. 1975 Jun 14;2(5971):594-5 PMID: 1131627
  13. Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone?
    Br J Pharmacol. 1973 Mar;47(3):615P PMID: 4730837
  14. Effect of diphenylhydantoin on hepatic drug hydroxylation.
    Eur J Clin Pharmacol. 1974 Jul 26;7(4):281-5 PMID: 4851632
  15. Dicoumarol-induced diphenylhydantoin intoxication.
    Lancet. 1966 Jul 30;2(7457):265-6 PMID: 4161425
  16. Biochemical and genetic factors regulating dilantin metabolism in man.
    Ann N Y Acad Sci. 1971 Jul 6;179:705-22 PMID: 4105796
  17. Letter: Anti-epileptic drugs and failure of oral contraceptives.
    Lancet. 1974 Sep 7;2(7880):600 PMID: 4140317
  18. Editorial: Paracetamol hepatotoxicity.
    Lancet. 1975 Dec 13;2(7946):1189-91 PMID: 53664
  19. Interaction between doxycycline and some antiepileptic drugs.
    Br Med J. 1974 Jun 1;2(5917):470-2 PMID: 4600204
  20. A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments.
    Epilepsia. 1975 Nov;16(4):627-46 PMID: 9890790
  21. Letter: Vitamin D therapy for children on anticonvulsants.
    N Engl J Med. 1975 Nov 20;293(21):1106 PMID: 170525
  22. The influence of diphenylhydantoin on primidone metabolism.
    Arch Neurol. 1974 Mar;30(3):259-62 PMID: 4812960
  23. Residual cerebellar systems dysfunction and peripheral neuropathy after diphenylhydantoin therapy.
    Mt Sinai J Med. 1972 Nov-Dec;39(6):617-21 PMID: 4344739
  24. Renal insensitivity to frusemide caused by chronic anticonvulsant therapy.
    Br Med J. 1974 Sep 14;3(5932):657-9 PMID: 4609534
  25. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.
    Clin Pharmacol Ther. 1970 Nov-Dec;11(6):846-55 PMID: 4394754
  26. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.
    N Engl J Med. 1972 May 25;286(21):1125-8 PMID: 4553339
  27. Inhibition of drug metabolism by chloramphenicol.
    Lancet. 1969 Dec 27;2(7635):1397-9 PMID: 4188280
  28. Clonazepam--a clinical study of its effectiveness as an anticonvulsant.
    Proc Aust Assoc Neurol. 1973;10(0):61-6 PMID: 4600355
  29. Plasma levels of lidocaine during combined treatment with phenytoin and procainamide.
    Eur J Clin Pharmacol. 1974 Oct 4;7(6):455-9 PMID: 4439869
  30. Drug interaction: diazoxide and diphenylhydantoin.
    J Pediatr. 1975 Sep;87(3):480-4 PMID: 1165531
  31. Influence of ethylphenacemide on serum levels of other anti-epileptic drugs.
    Epilepsia. 1970 Jun;11(2):207-15 PMID: 5270551
  32. Steady-state plasma nortriptyline concentrations in epileptic patients.
    Br J Clin Pharmacol. 1975 Oct;2(5):469-71 PMID: 1233074
  33. Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients.
    JAMA. 1968 Mar 11;203(11):969-72 PMID: 5694319
  34. AN EFFECT OF PHENOBARBITONE ON BLOOD-LEVELS OF GRISEOFULVIN IN MAN.
    Lancet. 1963 Nov 16;2(7316):1042-3 PMID: 14062729
  35. Increased rate of clearance of drugs from the circulation of alcoholics.
    Am J Med Sci. 1969 Jul;258(1):35-9 PMID: 4894493
  36. Interaction between phenytoin and the benzodiazepines.
    Br Med J. 1971 Feb 6;1(5744):346 PMID: 5541733
  37. The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine.
    Arch Neurol. 1967 Jun;16(6):642-4 PMID: 6026073
  38. Inhibition of phenytoin metabolism by sulthiame in epileptic patients.
    Br J Clin Pharmacol. 1974 Feb;1(1):59-66 PMID: 22454870
  39. Griseofulvin-phenobarbital interaction in man.
    JAMA. 1970 Jul 20;213(3):426-31 PMID: 5468016
  40. Pharmacological implications of microsomal enzyme induction.
    Pharmacol Rev. 1967 Sep;19(3):317-66 PMID: 4383307
  41. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.
    Epilepsia. 1968 Mar;9(1):17-22 PMID: 4386877
  42. Phenytoin intoxication induced by sulthiame in epileptic patients.
    J Neurol Neurosurg Psychiatry. 1974 Mar;37(3):275-81 PMID: 4151416
  43. Blood levels of diazepam (Valium) and N-desmethyl diazepam in the epileptic child. A preliminary report.
    Psychiatr Neurol Neurochir. 1971 Mar-Apr;74(2):153-8 PMID: 5149864
  44. Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.
    Br J Clin Pharmacol. 1975 Jun;2(3):197-208 PMID: 791320
  45. Clinical observations of possible barbiturate interference with anticoagulation.
    JAMA. 1968 Apr 8;204(2):97-100 PMID: 5694725
  46. Isoniazid as an inhibitor of primidone metabolism.
    Neurology. 1975 Dec;25(12):1179-81 PMID: 812007
  47. Interactions of antiepileptic drugs.
    Epilepsia. 1975 Jun;16(2):393-402 PMID: 50232
  48. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
    Lancet. 1968 Jun 15;1(7555):1275-9 PMID: 4172137
  49. Distribution and elimination kinetics of carbamazepine in man.
    Eur J Clin Pharmacol. 1975 Feb 28;8(2):91-6 PMID: 1233212
  50. Interaction of phenytoin with chlorpheniramine.
    Br J Clin Pharmacol. 1975 Apr;2(2):173-5 PMID: 1234500
Article Info
Journal
Drugs
Abbr.
Drugs
ISSN
0012-6667
Published
1977-04-00
Pages
266-75
Language
English
Region
New Zealand
NLM ID
7600076
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com